Comparative Efficacy of Intranasal Corticosteroids and Antihistamines in Enhancing Paediatric Quality of Life in Allergic Rhinoconjunctivitis

Key Points

• This research aims to compare the effectiveness of intranasal corticosteroids and antihistamines in improving quality of life in children with allergic rhinoconjunctivitis.
• Daily administration of intranasal corticosteroids and antihistamines was evaluated in different age groups.
• Participants included adolescents aged 12–18 years and children aged 6–11 years.
• Quality of life assessments were conducted post-treatment.
• Intranasal corticosteroids significantly improved quality of life in adolescents compared to antihistamines.
• Antihistamines provided greater quality of life enhancement in younger children than intranasal corticosteroids.